CRSwNP exhibits a prevalent type 2 inflammation in Western countries, characterized by interleukin (IL)-4, IL-5, and IL-13, and infiltration of nasal polyps by eosinophils, basophils, and mast cells [2,3]. The gene discussed is IL13; the disease is chronic rhinosinusitis with nasal polyps.